TegoScience Balance Sheet Health
Financial Health criteria checks 3/6
TegoScience has a total shareholder equity of ₩51.1B and total debt of ₩1.3B, which brings its debt-to-equity ratio to 2.6%. Its total assets and total liabilities are ₩53.7B and ₩2.6B respectively.
Key information
2.6%
Debt to equity ratio
₩1.31b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩27.91b |
| Equity | ₩51.07b |
| Total liabilities | ₩2.62b |
| Total assets | ₩53.70b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A191420's short term assets (₩33.0B) exceed its short term liabilities (₩2.3B).
Long Term Liabilities: A191420's short term assets (₩33.0B) exceed its long term liabilities (₩363.8M).
Debt to Equity History and Analysis
Debt Level: A191420 has more cash than its total debt.
Reducing Debt: A191420's debt to equity ratio has increased from 0% to 2.6% over the past 5 years.
Debt Coverage: A191420's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A191420's interest payments on its debt are well covered by EBIT.